Your browser doesn't support javascript.
loading
Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
Takala, Laura; Kuusinen, Tuuli-Elina; Skyttä, Tanja; Kellokumpu-Lehtinen, Pirkko-Liisa; Bärlund, Maarit.
Afiliación
  • Takala L; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland. Electronic address: laura.takala@fimnet.fi.
  • Kuusinen TE; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.
  • Skyttä T; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland; Department of Oncology, Tampere University Hospital, Tampere, Finland; Tays Cancer Centre, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Kellokumpu-Lehtinen PL; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland; Research, Development and Innovation Center, Tampere University Hospital, Tampere, Finland.
  • Bärlund M; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland; Department of Oncology, Tampere University Hospital, Tampere, Finland; Tays Cancer Centre, Tampere University Hospital and Tampere University, Tampere, Finland.
Clin Breast Cancer ; 21(3): e252-e270, 2021 06.
Article en En | MEDLINE | ID: mdl-33229222
ABSTRACT

INTRODUCTION:

Patient-reported outcomes (PROs) have become extremely important in following patients' health-related quality of life during cancer treatments. The aim of this study was to assess the usefulness of electronic PROs (ePROs) during adjuvant radiotherapy (RT) in patients with early breast cancer. MATERIALS AND

METHODS:

A registry trial was conducted with a total of 253 patients with breast cancer receiving RT. Adverse event data were collected from 9 items on the ePRO questionnaires that were administered before RT (N = 253), at the end of RT (± 3 days; N = 234), 1 month after RT (N = 230), and 3 months (N = 225) after RT. The patient characteristics and treatment details were collected from the medical records.

RESULTS:

The patients have started actively using the ePRO system, and the response rates were high (82.6%). During RT, 39.3% of the ePRO responses were about symptoms, and 60.7% were about treatment-related questions or advice. Patients treated with hypofractionated RT reported fewer local adverse events such as skin symptoms (P = .001) and pain (P = .002) than those who received conventional RT. One of the main findings of this study was that tiredness, fatigue, and anxiety were commonly reported on the patients' ePRO questionnaires, but they were rarely recorded in the medical records.

CONCLUSION:

Patients were motivated to use the ePRO system, and the response rates were high. Additionally, patients seemed to find that the ePRO system was an easy way to contact their own health care professionals. More attention should be paid to mental well-being during visits to the clinic.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Asunto principal: Neoplasias de la Mama / Sistemas de Registros Médicos Computarizados / Difusión de la Información / Medición de Resultados Informados por el Paciente Aspecto: Patient_preference Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Asunto principal: Neoplasias de la Mama / Sistemas de Registros Médicos Computarizados / Difusión de la Información / Medición de Resultados Informados por el Paciente Aspecto: Patient_preference Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
...